Saypha Volume Plus Lido (1x1 ml)

Patients should abstain from alcohol for at least 24 hours before and 48 hours after the procedure. Alcohol increases the risk of hematomas and can significantly worsen post-filler swelling, which is particularly important when injecting high volumes for facial contouring.

Injection is not recommended during lactation. There is currently no definitive data on the systemic absorption of lidocaine or cross-linked HA components into breast milk. It is advised to wait until the breastfeeding period is over before performing elective volumizing procedures.

The dosage is determined by the treating physician based on the degree of volume loss and the desired anatomical correction. A typical treatment for mid-face volumization involves 1 ml to 2 ml of gel per session. Injection technique is critical; using a cannula or needle for deep subcutaneous placement is standard practice for this high-viscosity formulation.

Common post-injection reactions include transient swelling, localized pressure, and tenderness. Because of its high concentration, patients may feel the product more prominently during the first few days. To support healing, review our comprehensive aftercare guide. Any persistent skin blanching or severe pain must be immediately evaluated for vascular occlusion.

The S.M.A.R.T. technology utilized in this gel creates a dense, reticulated HA matrix that resists mechanical degradation. Once injected, it acts as a structural scaffold, providing immediate lifting and volume. Unlike lighter skin boosters, this product is designed for long-term tissue support rather than superficial hydration.

This treatment is strictly contraindicated for pregnant women. Due to the lack of clinical trials evaluating the safety of highly cross-linked HA and lidocaine during gestation, practitioners must prioritize patient safety and defer treatment until after childbirth.

The formulation consists of highly cross-linked Hyaluronic Acid of non-animal origin at a concentration of 25 mg/ml, supplemented with 0.3% Lidocaine hydrochloride to reduce procedural discomfort.